• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者因金刚烷胺出现 Levido reticularis 的感知。

Patient perception of Levido reticularis due to amantadine.

机构信息

Parkinson's Clinic of Eastern Toronto & Movement Disorders Center, Toronto, Ontario, Canada.

出版信息

Int J Neurosci. 2012 Jul;122(7):363-6. doi: 10.3109/00207454.2012.668727. Epub 2012 Apr 23.

DOI:10.3109/00207454.2012.668727
PMID:22356509
Abstract

Livedo reticularis (LR) is a "fish-net like" mottling of the skin, and is attributed to a variety of factors. Amantadine, a medication used in Parkinson's disease, has been known to cause LR localized to the lower, and to a rarer extent, the upper extremities. Patient perception of this condition has been severely under-reported and can impact the patient's decision to stop this medication. In this retrospective study, we analyze the perception of five patients presenting with LR and their decision to continue on amantadine. It was seen that patients with the reticularis rash localized in the upper extremities, in addition to the lower extremities, were affected enough to discontinue amantadine despite its useful therapeutic effects. It is imperative that patient perception regarding LR be taken into consideration when initially presented. Furthermore, the decision to change the regiment of amantadine should be individualized according to patient condition and perception of presented rash.

摘要

网状青斑(LR)是一种“网状”皮肤斑驳,归因于多种因素。金刚烷胺,一种用于帕金森病的药物,已知会导致 LR 局限于下肢,更罕见的情况下也会累及上肢。患者对这种情况的感知被严重低估,可能会影响他们停止服用这种药物的决定。在这项回顾性研究中,我们分析了五名出现 LR 的患者的感知及其继续服用金刚烷胺的决定。我们发现,网状皮疹不仅局限于下肢,还局限于上肢的患者,即使金刚烷胺有有效的治疗效果,也会因皮疹而停药。当最初出现 LR 时,必须考虑患者的感知。此外,根据患者的病情和对皮疹的感知,应个体化决定是否改变金刚烷胺的治疗方案。

相似文献

1
Patient perception of Levido reticularis due to amantadine.患者因金刚烷胺出现 Levido reticularis 的感知。
Int J Neurosci. 2012 Jul;122(7):363-6. doi: 10.3109/00207454.2012.668727. Epub 2012 Apr 23.
2
Livedo reticularis from amantadine.金刚烷胺所致网状青斑
Skinmed. 2011 Sep-Oct;9(5):320-1.
3
Amantadine-induced livedo reticularis: a report of two cases.金刚烷胺诱发的网状青斑:两例报告。
J Drugs Dermatol. 2006 Mar;5(3):288-9.
4
Late onset of livedo reticularis induced by amantadine treatment concomitant with erythrocytosis.金刚烷胺治疗伴红细胞增多症诱发的迟发性网状青斑
Eur J Dermatol. 2012 Mar-Apr;22(2):273-4. doi: 10.1684/ejd.2012.1642.
5
Amantadine-induced livedo reticularis--Case report.金刚烷胺诱发的网状青斑——病例报告。
An Bras Dermatol. 2015 Sep-Oct;90(5):745-7. doi: 10.1590/abd1806-4841.20153394.
6
Amantadine-Induced Livedo Racemosa.金刚烷胺诱发的双侧性网状青斑
Int J Low Extrem Wounds. 2016 Mar;15(1):78-81. doi: 10.1177/1534734615603566. Epub 2015 Sep 3.
7
Case for diagnosis.诊断病例
An Bras Dermatol. 2012 Mar-Apr;87(2):319-21. doi: 10.1590/s0365-05962012000200025.
8
[Livedo reticularis secondary to amantadine in a patient with Parkinson disease].[帕金森病患者中金刚烷胺继发的网状青斑]
Med Clin (Barc). 2014 Feb 20;142(4):186. doi: 10.1016/j.medcli.2013.06.022. Epub 2013 Sep 6.
9
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.金刚乙胺用于对金刚烷胺产生外周不良反应的帕金森病患者:病例系列报告
Mov Disord. 2005 Jul;20(7):873-7. doi: 10.1002/mds.20471.
10
Likely amantadine-induced livedo reticularis in a child.一名儿童可能因金刚烷胺诱发网状青斑。
Pediatr Dermatol. 2012 May-Jun;29(3):329-30. doi: 10.1111/j.1525-1470.2011.01437.x. Epub 2011 Oct 13.

引用本文的文献

1
The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.皮肤与帕金森病:临床、诊断及治疗问题综述
Mov Disord Clin Pract. 2016 Sep 8;4(1):21-31. doi: 10.1002/mdc3.12425. eCollection 2017 Jan-Feb.
2
Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.金刚烷胺治疗 L-DOPA 诱导的运动障碍的疗效和安全性。
J Neural Transm (Vienna). 2018 Aug;125(8):1237-1250. doi: 10.1007/s00702-018-1869-1. Epub 2018 Mar 7.
3
Skin disorders in Parkinson's disease: potential biomarkers and risk factors.
帕金森病中的皮肤疾病:潜在生物标志物和风险因素。
Clin Cosmet Investig Dermatol. 2017 Mar 9;10:87-92. doi: 10.2147/CCID.S130319. eCollection 2017.
4
Cutaneous Adverse Effects of Neurologic Medications.神经科药物的皮肤不良反应
CNS Drugs. 2016 Mar;30(3):245-67. doi: 10.1007/s40263-016-0318-7.